Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers

JAMA

Volumn 304, Issue 24, 2010, Pages 2695-

  Heemskerk Gerritsen, Bernadette A M ^a   Kriege, Mieke ^a   Seynaeve, Caroline ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER MORTALITY; CANCER RISK; FEMALE; FOLLOW UP; GENE MUTATION; GROUPS BY AGE; HETEROZYGOTE; HUMAN; LETTER; ONCOGENE; PRIORITY JOURNAL; RISK REDUCTION; SALPINGOOOPHORECTOMY; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MORTALITY; NOTE; OVARIECTOMY; OVARY TUMOR; RISK; SECOND CANCER; TUMOR SUPPRESSOR GENE; UTERINE TUBE;

BREAST NEOPLASMS; FALLOPIAN TUBES; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; OVARIECTOMY; RESEARCH DESIGN; RISK;

EID: 78650509488     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1854     Document Type: Letter

References (2)

1. Domchek SM, Friebel TM, Singer CF, et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967-975.
2. Klaren HM, van't Veer LJ, van Leeuwen FE, Rookus MA. Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. J Natl Cancer Inst. 2003;95(13):941-947.